Medical Developments International | MVP - Creditori Commerciali

Prezzo Delle Azioni
0.43
Cambio Giornaliero
0 0%
Mensile
-9.47%
Annuale
-30.65%
Q1 Previsione
0.43




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 6.7M 1.3M 2025-09
Genetic Signatures AUD 3.63M 1.25M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Medical Developments International AUD 4.31M 2.18M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Paradigm Biopharmaceuticals AUD 2.73M 2.15M 2025-06
PYC Therapeutics AUD 9.56M 802.76K 2025-12
Starpharma Holdings AUD 2.67M 618K 2025-12
Tectonic Therapeutic USD 1.48M 1.32M 2025-09
Telix Pharmaceuticals AUD 71.66M 19.98M 2025-12
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 6.53M 2.93M 2025-09